FDA Inspection 1050979 — Alnylam Pharmaceuticals, Inc.
The FDA completed an inspection of Alnylam Pharmaceuticals, Inc. on Apr 25, 2018 in Cambridge, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 25, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cambridge, MA (United States)
Additional details
Sponsor, Contract Research Organization